Chronic obstructive pulmonary disease (COPD) is a leading cause of chronic morbidity and mortality worldwide and is projected to become the third leading cause of death by 2020. The burden of COPD is ...

An analysis of adoption of and adherence to chronic obstructive pulmonary disease (COPD) Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines in the primary care setting unearthed ...

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. It is a chronic disease that affects quality of life and mobility, and can lead to respiratory ...

Per the new guidelines, for patients with stable COPD, the main treatment goal would be to reduce symptoms and future exacerbation risk. With this in mind, the GOLD Report includes the following key ...

• LAMA/LABA therapy now an essential cornerstone for COPD treatment across the spectrum of people with COPD in GOLD groups B-D 1 INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim welcomes the ...

—The 2019 GOLD guidelines emphasize the need for separate strategies for initial and follow-up pharmacotherapy and the importance of using of eosinophil counts to decide about inhaled corticosteroid ...

Clinical guidelines recommend long-acting bronchodilators as first maintenance therapy for chronic obstructive pulmonary disease (COPD), with inhaled corticosteroids (ICS) reserved for patients with ...

All of them can make you feel breathless. Doctors use stages to describe how severe your COPD is. This system is called the GOLD staging or grading system. Your grade will affect what treatment you ...

Primary care physicians manage the majority of individuals in the United States with COPD. [10] In many areas of the country where COPD mortality is high such as Nevada and the Appalachian Mountain ...